{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:36:15Z","timestamp":1792989375397,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tel Aviv University","id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The treatment of tic disorders in children and adolescents poses significant challenges, especially when comorbid conditions such as obsessive-compulsive disorder (OCD) and attention-deficit\/hyperactivity disorder (ADHD) are present. Pharmacological treatments are often guided by clinical judgment, prescriber preferences, and medication availability. This study describes pharmacological treatment use in a large cohort of children and adolescents with chronic tic disorders (CTDs). We analyzed baseline data from the European Multicenter Tics in Children Study (EMTICS) to examine associations between medication use, tic severity, and psychiatric comorbidities, using parent-reported questionnaires and clinical interviews to assess tics, obsessive-compulsive disorder (OCD), attention-deficit\/hyperactivity disorder (ADHD), oppositional defiant disorder (ODD), and children\u2019s self-rated premonitory urges. Among 709 children aged 3\u201316 years with CTDs, 230 (32%) received any pharmacological treatment, 22% received antipsychotics and 10% received ADHD medications, with limited use of alpha-2 agonists (3%). Medication use was more common among individuals with comorbid ADHD (54%) than those with CTD only (23%) or comorbid OCD only (26%). Those on tic-suppressing medications had significantly greater severity of tics, tic-related impairment, and comorbid ADHD, ODD, and obsessive symptom severity compared to those with non-tic-suppressing medications. There was no relationship with the severity of compulsions or premonitory urges. While largely consistent with published guidelines, these findings indicate limited utilization of recommended agents, such as alpha-2 agonists, alongside higher reported symptom severity among those receiving tic-suppressing medications. Further studies should explore the integration of pharmacological, behavioral, and psychoeducational approaches tailored to comorbidity profiles and symptom severity.<\/jats:p>","DOI":"10.1007\/s00787-026-03120-5","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:10:57Z","timestamp":1784290257000},"page":"3657-3672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medication use and treatment patterns in children and adolescents with chronic tic disorders: an EMTICS study"],"prefix":"10.1007","volume":"35","author":[{"given":"Orit","family":"Peled","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphna","family":"Shoham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Apter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Feldman-Sadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miri","family":"Carmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idan","family":"Barak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsanett","family":"Tarnok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter J.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the EMTICS collaborative group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Apter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Benaroya-Milshtein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Buse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Correa","family":"Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Fremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Garcia-Delgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy J.","family":"Hedderly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isobel","family":"Heyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter J.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaim","family":"Huijser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Madruga","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Morer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"M\u00fcller-Vah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"M\u00fcnchau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin J.","family":"Plessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Porcelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Roessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphna","family":"Ruhrman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Schrag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsanett","family":"Tarnok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Visscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Walitza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Weidinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Benaroya-Milshtein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"issue":"2","key":"3120_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00787-014-0563-6","volume":"24","author":"CJ Bachmann","year":"2015","unstructured":"Bachmann CJ, Roessner V, Glaeske G, Hoffmann F (2015) Trends in psychopharmacologic treatment of tic disorders in children and adolescents in Germany. Eur Child Adolesc Psychiatry 24(2):199\u2013207. https:\/\/doi.org\/10.1007\/s00787-014-0563-6","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"11","key":"3120_CR2","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.3390\/jcm10112479","volume":"10","author":"K Ueda","year":"2021","unstructured":"Ueda K, Black KJ (2021) A Comprehensive Review of Tic Disorders in Children. J Clin Med 10(11):2479. https:\/\/doi.org\/10.3390\/jcm10112479","journal-title":"J Clin Med"},{"issue":"10","key":"3120_CR3","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00787-019-01450-1","volume":"29","author":"TJC Openneer","year":"2020","unstructured":"Openneer TJC, T\u00e1rnok Z, Bognar E et al (2020) The Premonitory Urge for Tics Scale in a large sample of children and adolescents: psychometric properties in a developmental context. An EMTICS study. Eur Child Adolesc Psychiatry 29(10):1411\u20131424. https:\/\/doi.org\/10.1007\/s00787-019-01450-1","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"3120_CR4","doi-asserted-by":"publisher","unstructured":"Cothros N, Martino D, McMorris C, Stewart D, Tehrani A, Pringsheim T (2019) Prescriptions for Alpha Agonists and Antipsychotics in Children and Youth with Tic Disorders: A Pharmacoepidemiologic Study. Tremor Other Hyperkinet Mov (N Y) 9. https:\/\/doi.org\/10.7916\/tohm.v0.645","DOI":"10.7916\/tohm.v0.645"},{"key":"3120_CR5","unstructured":"Association AP (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR). American Psychiatric Association"},{"issue":"10","key":"3120_CR6","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00787-021-01751-4","volume":"31","author":"B Garcia-Delgar","year":"2022","unstructured":"Garcia-Delgar B, Servera M, Coffey BJ et al (2022) Tic disorders in children and adolescents: does the clinical presentation differ in males and females? A report by the EMTICS group. Eur Child Adolesc Psychiatry 31(10):1539\u20131548. https:\/\/doi.org\/10.1007\/s00787-021-01751-4","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"3","key":"3120_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00787-021-01899-z","volume":"31","author":"V Roessner","year":"2022","unstructured":"Roessner V, Eichele H, Stern JS et al (2022) European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment. Eur Child Adolesc Psychiatry 31(3):425\u2013441. https:\/\/doi.org\/10.1007\/s00787-021-01899-z","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"3120_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fpsyt.2018.00100","volume":"9","author":"R Rizzo","year":"2018","unstructured":"Rizzo R, Pellico A, Silvestri PR, Chiarotti F, Cardona F (2018) A Randomized Controlled Trial Comparing Behavioral, Educational, and Pharmacological Treatments in Youths With Chronic Tic Disorder or Tourette Syndrome. Front Psychiatry 9:100. https:\/\/doi.org\/10.3389\/fpsyt.2018.00100","journal-title":"Front Psychiatry"},{"issue":"4","key":"3120_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s40474-015-0063-5","volume":"2","author":"JF McGuire","year":"2015","unstructured":"McGuire JF, Ricketts EJ, Piacentini J, Murphy TK, Storch EA, Lewin AB (2015) Behavior Therapy for Tic Disorders: An Evidenced-based Review and New Directions for Treatment Research. Curr Dev Disord Rep 2(4):309\u2013317. https:\/\/doi.org\/10.1007\/s40474-015-0063-5","journal-title":"Curr Dev Disord Rep"},{"key":"3120_CR10","doi-asserted-by":"publisher","unstructured":"Rasmussen L, Bilenberg N, Thrane JM, Ernst MT, Potteg\u00e5rd A, Rasmussen, Lotte N, Bilenberg (2020) Julie Maria Thrane, Martin Thomsen Ernst, and Anton Potteg\u00e5rd. Use of Tic-Suppressing Medication and Other Psychotropic Drugs in Children and Adolescents with Newly Diagnosed Tic Disorders in Denmark. Journal of Child and Adolescent Psychopharmacology 30, no. 8 : 476\u201385. https:\/\/doi.org\/10.1089\/cap.2020.0060. J Child Adolesc Psychopharmacol. 2020;30(8):476\u2013485. doi:10.1089\/cap.2020.0060","DOI":"10.1089\/cap.2020.0060"},{"issue":"19","key":"3120_CR11","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1212\/WNL.0000000000007467","volume":"92","author":"T Pringsheim","year":"2019","unstructured":"Pringsheim T, Holler-Managan Y, Okun MS et al (2019) Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 92(19):907\u2013915. https:\/\/doi.org\/10.1212\/WNL.0000000000007467","journal-title":"Neurology"},{"issue":"19","key":"3120_CR12","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1212\/WNL.0000000000007466","volume":"92","author":"T Pringsheim","year":"2019","unstructured":"Pringsheim T, Okun MS, M\u00fcller-Vahl K et al (2019) Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 92(19):896\u2013906. https:\/\/doi.org\/10.1212\/WNL.0000000000007466","journal-title":"Neurology"},{"issue":"4","key":"3120_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/14737175.2021.1893693","volume":"21","author":"JH Cox","year":"2021","unstructured":"Cox JH, Cavanna AE (2021) Aripiprazole for the treatment of Tourette syndrome. Expert Rev Neurother 21(4):381\u2013391. https:\/\/doi.org\/10.1080\/14737175.2021.1893693","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"3120_CR14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.eurpsy.2009.10.003","volume":"26","author":"M Schlander","year":"2011","unstructured":"Schlander M, Schwarz O, Rothenberger A, Roessner V (2011) Tic disorders: Administrative prevalence and co-occurrence with attention-deficit\/hyperactivity disorder in a German community sample. Eur Psychiatry 26(6):370\u2013374. https:\/\/doi.org\/10.1016\/j.eurpsy.2009.10.003","journal-title":"Eur Psychiatry"},{"issue":"1","key":"3120_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00787-018-1190-4","volume":"28","author":"A Schrag","year":"2019","unstructured":"EMTICS Collaborative Group, Schrag A, Martino D et al (2019) European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescents. Eur Child Adolesc Psychiatry 28(1):91\u2013109. https:\/\/doi.org\/10.1007\/s00787-018-1190-4","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"2","key":"3120_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00787-014-0563-6","volume":"24","author":"CJ Bachmann","year":"2015","unstructured":"Bachmann CJ, Roessner V, Glaeske G, Hoffmann F (2015) Trends in psychopharmacologic treatment of tic disorders in children and adolescents in Germany. Eur Child Adolesc Psychiatry 24(2):199\u2013207. https:\/\/doi.org\/10.1007\/s00787-014-0563-6","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"4","key":"3120_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","volume":"28","author":"JF Leckman","year":"1989","unstructured":"Leckman JF, Riddle MA, Hardin MT et al (1989) The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28(4):566\u2013573. https:\/\/doi.org\/10.1097\/00004583-198907000-00015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"3120_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/mds.26891","volume":"32","author":"D Martino","year":"2017","unstructured":"Martino D, Pringsheim TM, Cavanna AE et al (2017) Systematic Review of Severity Scales and Screening Instruments for Tics: Critique and Recommendations. Mov Disord 32(3):467\u2013473. https:\/\/doi.org\/10.1002\/mds.26891","journal-title":"Mov Disord"},{"key":"3120_CR19","doi-asserted-by":"publisher","unstructured":"Haas M, Jakubovski E, Fremer C et al (2021) Yale Global Tic Severity Scale (YGTSS): Psychometric Quality of the Gold Standard for Tic Assessment Based on the Large-Scale EMTICS Study. Front Psychiatry 12. https:\/\/doi.org\/10.3389\/fpsyt.2021.626459","DOI":"10.3389\/fpsyt.2021.626459"},{"issue":"11","key":"3120_CR20","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","volume":"46","author":"WK Goodman","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA et al (1989) The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46(11):1006\u20131011. https:\/\/doi.org\/10.1001\/archpsyc.1989.01810110048007","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"3120_CR21","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/00004583-199706000-00023","volume":"36","author":"L Scahill","year":"1997","unstructured":"Scahill L, Riddle MA, McSwiggin-Hardin M et al (1997) Children\u2019s Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 36(6):844\u2013852. https:\/\/doi.org\/10.1097\/00004583-199706000-00023","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"8","key":"3120_CR22","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.janxdis.2006.01.006","volume":"20","author":"EA Storch","year":"2006","unstructured":"Storch EA, Murphy TK, Adkins JW et al (2006) The children\u2019s Yale-Brown obsessive-compulsive scale: psychometric properties of child- and parent-report formats. J Anxiety Disord 20(8):1055\u20131070. https:\/\/doi.org\/10.1016\/j.janxdis.2006.01.006","journal-title":"J Anxiety Disord"},{"key":"3120_CR23","doi-asserted-by":"publisher","unstructured":"Novara C, Pardini S, Cardona F, Pastore M (2020) Comparing Models of the Children\u2019s Yale-Brown Obsessive-Compulsive Scale (CY-BOCS) in an Italian Clinical Sample. Frontiers in Psychiatry. ;11. Accessed December 8, 2023. https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fpsyt.2020.00615","DOI":"10.3389\/fpsyt.2020.00615"},{"issue":"1","key":"3120_CR24","first-page":"51","volume":"10","author":"JM Swanson","year":"2012","unstructured":"Swanson JM, Schuck S, Porter MM et al (2012) Categorical and Dimensional Definitions and Evaluations of Symptoms of ADHD: History of the SNAP and the SWAN Rating Scales. Int J Educ Psychol Assess 10(1):51\u201370","journal-title":"Int J Educ Psychol Assess"},{"issue":"3","key":"3120_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/1073191107313888","volume":"15","author":"R Bussing","year":"2008","unstructured":"Bussing R, Fernandez M, Harwood M et al (2008) Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: psychometric properties and normative ratings from a school district sample. Assessment 15(3):317\u2013328. https:\/\/doi.org\/10.1177\/1073191107313888","journal-title":"Assessment"},{"issue":"2","key":"3120_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/00004583-200102000-00011","volume":"40","author":"JM Swanson","year":"2001","unstructured":"Swanson JM, Kraemer HC, Hinshaw SP et al (2001) Clinical Relevance of the Primary Findings of the MTA: Success Rates Based on Severity of ADHD and ODD Symptoms at the End of Treatment. J Am Acad Child Adolesc Psychiatry 40(2):168\u2013179. https:\/\/doi.org\/10.1097\/00004583-200102000-00011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"3120_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1023\/a:1023040610384","volume":"29","author":"S Ehlers","year":"1999","unstructured":"Ehlers S, Gillberg C, Wing L (1999) A screening questionnaire for Asperger syndrome and other high-functioning autism spectrum disorders in school age children. J Autism Dev Disord 29(2):129\u2013141. https:\/\/doi.org\/10.1023\/a:1023040610384","journal-title":"J Autism Dev Disord"},{"issue":"6","key":"3120_CR28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/00004703-200512000-00001","volume":"26","author":"DW Woods","year":"2005","unstructured":"Woods DW, Piacentini J, Himle MB, Chang S (2005) Premonitory Urge for Tics Scale (PUTS): initial psychometric results and examination of the premonitory urge phenomenon in youths with Tic disorders. J Dev Behav Pediatr 26(6):397\u2013403. https:\/\/doi.org\/10.1097\/00004703-200512000-00001","journal-title":"J Dev Behav Pediatr"},{"issue":"4","key":"3120_CR29","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00702-017-1818-4","volume":"125","author":"JM Raines","year":"2018","unstructured":"Raines JM, Edwards KR, Sherman MF et al (2018) Premonitory Urge for Tics Scale (PUTS): replication and extension of psychometric properties in youth with chronic tic disorders (CTDs). J Neural Transm 125(4):727\u2013734. https:\/\/doi.org\/10.1007\/s00702-017-1818-4","journal-title":"J Neural Transm"},{"key":"3120_CR30","unstructured":"Enders CK (2010) Applied Missing Data Analysis. Guilford Press, p xv"},{"key":"3120_CR31","doi-asserted-by":"publisher","unstructured":"Dobson AJ, Barnett AG (2018) An Introduction to Generalized Linear Models, 4th edn. Chapman and Hall\/CRC. https:\/\/doi.org\/10.1201\/9781315182780","DOI":"10.1201\/9781315182780"},{"issue":"1","key":"3120_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s11336-020-09698-2","volume":"85","author":"S Vandekar","year":"2020","unstructured":"Vandekar S, Tao R, Blume J (2020) A Robust Effect Size Index. Psychometrika 85(1):232\u2013246. https:\/\/doi.org\/10.1007\/s11336-020-09698-2","journal-title":"Psychometrika"},{"key":"3120_CR33","unstructured":"Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences. L. Erlbaum Associates"},{"issue":"6","key":"3120_CR34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/hup.2495","volume":"30","author":"M Farag","year":"2015","unstructured":"Farag M, Stern JS, Simmons H, Robertson MM (2015) Serial pharmacological prescribing practices for tic management in Tourette syndrome. Hum Psychopharmacol 30(6):435\u2013441. https:\/\/doi.org\/10.1002\/hup.2495","journal-title":"Hum Psychopharmacol"},{"key":"3120_CR35","unstructured":"Themes UFO (2025) Evidence-Based Assessment of Tourette Syndrome. Neupsy Key. May 25, Accessed October 24, 2025. https:\/\/neupsykey.com\/evidence-based-assessment-of-tourette-syndrome\/"},{"key":"3120_CR36","doi-asserted-by":"publisher","unstructured":"Ramsey KA, De Nadai AS, Espil FM et al (2022) Urge intolerance predicts tic severity and impairment among adults with Tourette syndrome and chronic tic disorders. Front Psychiatry 13. https:\/\/doi.org\/10.3389\/fpsyt.2022.929413","DOI":"10.3389\/fpsyt.2022.929413"},{"issue":"9","key":"3120_CR37","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/jcpp.12556","volume":"57","author":"C Whittington","year":"2016","unstructured":"Whittington C, Pennant M, Kendall T et al (2016) Practitioner Review: Treatments for Tourette syndrome in children and young people \u2013 a systematic review. J Child Psychol Psychiatry 57(9):988\u20131004. https:\/\/doi.org\/10.1111\/jcpp.12556","journal-title":"J Child Psychol Psychiatry"},{"issue":"11","key":"3120_CR38","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1080\/14737175.2019.1643236","volume":"19","author":"JKY Essoe","year":"2019","unstructured":"Essoe JKY, Grados MA, Singer HS, Myers NS, McGuire JF (2019) Evidence-based treatment of Tourette\u2019s disorder and chronic tic disorders. Expert Rev Neurother 19(11):1103\u20131115. https:\/\/doi.org\/10.1080\/14737175.2019.1643236","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"3120_CR39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ejpn.2011.12.001","volume":"16","author":"H Rickards","year":"2012","unstructured":"Rickards H, Cavanna AE, Worrall R (2012) Treatment practices in Tourette syndrome: the European perspective. Eur J Paediatr Neurol 16(4):361\u2013364. https:\/\/doi.org\/10.1016\/j.ejpn.2011.12.001","journal-title":"Eur J Paediatr Neurol"},{"issue":"4","key":"3120_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","volume":"20","author":"V Roessner","year":"2011","unstructured":"Roessner V, Plessen KJ, Rothenberger A et al (2011) European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry 20(4):173\u2013196. https:\/\/doi.org\/10.1007\/s00787-011-0163-7","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"9","key":"3120_CR41","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1089\/cap.2017.0024","volume":"27","author":"TK Murphy","year":"2017","unstructured":"Murphy TK, Fernandez TV, Coffey BJ et al (2017) Extended-Release Guanfacine Does Not Show a Large Effect on Tic Severity in Children with Chronic Tic Disorders. J Child Adolesc Psychopharmacol 27(9):762\u2013770. https:\/\/doi.org\/10.1089\/cap.2017.0024","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"3120_CR42","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.neubiorev.2012.09.008","volume":"37","author":"H Weisman","year":"2013","unstructured":"Weisman H, Qureshi IA, Leckman JF, Scahill L, Bloch MH (2013) Systematic review: pharmacological treatment of tic disorders\u2013efficacy of antipsychotic and alpha-2 adrenergic agonist agents. Neurosci Biobehav Rev 37(6):1162\u20131171. https:\/\/doi.org\/10.1016\/j.neubiorev.2012.09.008","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"3120_CR43","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/mdc3.12472","volume":"4","author":"JL Smith","year":"2017","unstructured":"Smith JL, Gregory S, McBride N, Murphy TK, Storch EA (2017) Outpatient Treatment of Tic Disorders Among Children and Adults. Mov Disord Clin Pract 4(4):559\u2013567. https:\/\/doi.org\/10.1002\/mdc3.12472","journal-title":"Mov Disord Clin Pract"},{"key":"3120_CR44","doi-asserted-by":"publisher","first-page":"113400","DOI":"10.1016\/j.psychres.2020.113400","volume":"293","author":"SB Wolicki","year":"2020","unstructured":"Wolicki SB, Bitsko RH, Holbrook JR et al (2020) Treatment use among children with Tourette syndrome living in the United States, 2014. Psychiatry Res 293:113400. https:\/\/doi.org\/10.1016\/j.psychres.2020.113400","journal-title":"Psychiatry Res"},{"issue":"4","key":"3120_CR45","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s40474-015-0061-7","volume":"2","author":"BJ Coffey","year":"2015","unstructured":"Coffey BJ (2015) Complexities for Assessment and Treatment of Co-Occurring ADHD and Tics. Curr Dev Disord Rep 2(4):293\u2013299. https:\/\/doi.org\/10.1007\/s40474-015-0061-7","journal-title":"Curr Dev Disord Rep"},{"issue":"4","key":"3120_CR46","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1177\/0883073820967518","volume":"36","author":"JF Garris","year":"2021","unstructured":"Garris JF, Huddleston DA, Jackson HS, Horn PS, Gilbert DL (2021) Implementation of the Mini-Child Tourette Syndrome Impairment Scale: Relationships to Symptom Severity and Treatment Decisions. J Child Neurol 36(4):288\u2013295. https:\/\/doi.org\/10.1177\/0883073820967518","journal-title":"J Child Neurol"},{"issue":"3","key":"3120_CR47","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00787-021-01845-z","volume":"31","author":"P Andr\u00e9n","year":"2022","unstructured":"Andr\u00e9n P, Jakubovski E, Murphy TL et al (2022) European clinical guidelines for Tourette syndrome and other tic disorders\u2014version 2.0. Part II: psychological interventions. Eur Child Adolesc Psychiatry 31(3):403\u2013423. https:\/\/doi.org\/10.1007\/s00787-021-01845-z","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"3120_CR48","unstructured":"CDC. Treatment of Tourette Syndrome. Tourette Syndrome. June 20 (2025) Accessed July 21, 2025. https:\/\/www.cdc.gov\/tourette-syndrome\/treatment\/index.html"},{"issue":"6","key":"3120_CR49","doi-asserted-by":"publisher","first-page":"CD007990","DOI":"10.1002\/14651858.CD007990.pub3","volume":"6","author":"ST Osland","year":"2018","unstructured":"Osland ST, Steeves TD, Pringsheim T (2018) Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. Cochrane Database Syst Rev 6(6):CD007990. https:\/\/doi.org\/10.1002\/14651858.CD007990.pub3","journal-title":"Cochrane Database Syst Rev"}],"container-title":["European Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-03120-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-026-03120-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-03120-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:23:38Z","timestamp":1792988618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-026-03120-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["3120"],"URL":"https:\/\/doi.org\/10.1007\/s00787-026-03120-5","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}